$SNDL

SNDL Inc.

No enriched coverage for $SNDL in the last 7 days.

No SEC Form 4 filings for $SNDL in the last 30 days.

Med

Alberta-based retailer hit by Canadians drinking less booze, smoking less weed

SNDL Inc, an Edmonton-based liquor and cannabis retailer, reported Q2 revenue down about 4% to $235.8 million and a nearly $8 million loss. Liquor sales fell about 5% to $134.7 million and cannabis store sales slipped 1.4% to $83.2 million. Management cited weaker Canadian demand and vape production issues, and said U.S. retail expansion in Florida, Texas and Massachusetts is pending.

SNDL Reports Second Quarter 2026 Financial and Operational Results

SNDL Inc. reported Q2 2026 results for the quarter ended June 30, 2026. Net revenue fell 3.7% to C$235.8M and gross profit declined 16.6% to C$56.3M. Operating loss was C$(7.8)M. Cash flow was C$(30.2)M, with free cash flow C$(6.7)M. SNDL said it had C$183.2M unrestricted cash and no debt, and repurchased 11.7M shares. It also said a restructuring of Surterra’s Parallel is expected to give it control of medical cannabis operations in coming months.

SNDL Announces Completion of Parallel Asset Acquisition and Positions for Nasdaq-Consolidated U.S. Medical Cannabis Operations

SNDL Inc. (NASDAQ: SNDL) said it completed the April 29, 2026 acquisition of assets from Surterra Holdings and affiliates via a strict foreclosure. The deal reduces about US$842 million of Parallel debt and gives SNDL indirect majority economic exposure equivalent to 66.7% of TransactionCo equity and 69.4% of debt. Acquired assets include 56 retail and 3 cultivation/manufacturing sites with about US$150 million annualized revenue.

SNDL sentiment & insider activity

Recent SNDL coverage spans financial news, earnings and mergers & acquisitions.

What's driving SNDL

  • Near-term earnings pressure from affordability-driven demand softness, partially offset by cash and a pending US retail expansion deal.

    calgarysun.com · Jul 29, 2026

  • Q2 showed revenue and gross profit declines alongside continued buybacks and a restructuring milestone tied to gaining control of Parallel’s Florida, Texas, and Massachusetts medical cannabis operations.

    leaderpost.com · Jul 28, 2026

  • Completion of the Parallel Transaction is a material balance-sheet and consolidation catalyst, though near-term financial statement impact is limited until legal and accounting steps finish.

    leaderpost.com · Jul 27, 2026

  • Deal failure changes capital allocation and removes expected retail expansion, but buyback intent may cushion sentiment.

    theglobeandmail.com · May 28, 2026

  • SNDL's strategic cost-cutting measures and focus on international expansion suggest potential for improved profitability in the medium term. However, current revenue pressures and negative free cash flow indicate ongoing challenges.

    TipRanks · Apr 30, 2026

alphai scores every news story that mentions SNDL with an AI model for sentiment and relevance, and aggregates insider trades from SNDL Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $SNDL

Score
$SNDLMedAI 8/10

Alberta-based retailer hit by Canadians drinking less booze, smoking less weed

SNDL Inc, an Edmonton-based liquor and cannabis retailer, reported Q2 revenue down about 4% to $235.8 million and a nearly $8 million loss. Liquor sales fell about 5% to $134.7 million and cannabis store sales slipped 1.4% to $83.2 million. Management cited weaker Canadian demand and vape production issues, and said U.S. retail expansion in Florida, Texas and Massachusetts is pending.

$SNDLMedAI 8/10

SNDL Reports Second Quarter 2026 Financial and Operational Results

SNDL Inc. reported Q2 2026 results for the quarter ended June 30, 2026. Net revenue fell 3.7% to C$235.8M and gross profit declined 16.6% to C$56.3M. Operating loss was C$(7.8)M. Cash flow was C$(30.2)M, with free cash flow C$(6.7)M. SNDL said it had C$183.2M unrestricted cash and no debt, and repurchased 11.7M shares. It also said a restructuring of Surterra’s Parallel is expected to give it control of medical cannabis operations in coming months.

$SNDLMedAI 8/10

SNDL Announces Completion of Parallel Asset Acquisition and Positions for Nasdaq-Consolidated U.S. Medical Cannabis Operations

SNDL Inc. (NASDAQ: SNDL) said it completed the April 29, 2026 acquisition of assets from Surterra Holdings and affiliates via a strict foreclosure. The deal reduces about US$842 million of Parallel debt and gives SNDL indirect majority economic exposure equivalent to 66.7% of TransactionCo equity and 69.4% of debt. Acquired assets include 56 retail and 3 cultivation/manufacturing sites with about US$150 million annualized revenue.

$CIAMedAI 8/10

Small caps to watch: Earnings from EQB, Coveo, Champion Iron and more

Canada’s S&P/TSX Small Cap Index is up about 67% over 52 weeks (record 1,472.68 on May 13), while the U.S. Russell 2000 is up about 40% (record 2,932.74 on Wednesday). EQB beat Q2 revenue/adjusted EPS but credit-loss provisions rose to $45.4M; revenue was $302–4M. Coveo’s Q4 matched expectations, but FY27 SaaS growth guidance (~9.5%) was seen below forecasts. Champion Iron Q4 revenue fell to $414.5M and net income to $23.2M. SNDL said its Ontario store purchase won’t proceed; it plans to realloc

$SNDLMed

SNDL Inc. Earnings Call: Cost Cuts Amid Cannabis Strain

SNDL Inc.'s recent earnings call highlighted revenue and margin pressures, especially in cannabis operations and liquor demand, but also emphasized strategic initiatives like the exclusive Jeter cannabis brand partnership, share buybacks, and cost savings. The company aims to restore momentum through a profit enhancement plan targeting over $20 million in operating income and increased international sales. Despite a top-line decline and negative free cash flow, SNDL foresees improved trends later in 2026, banking on these strategic shifts and regulatory tailwinds for its SunStream credit portfolio.

$SNDLMed

SNDL Sets April 29 Date to Report First-Quarter 2026 Results

SNDL Inc. announced it will release its first-quarter 2026 financial results before market open on April 29, 2026, followed by a conference call and live webcast at 10:00 a.m. EDT to discuss its performance and market position. Analysts currently rate SNDL stock as a Buy with a $4.50 price target, though TipRanks’ AI Analyst, Spark, assigns a Neutral rating due to incomplete profitability and weak technical signals, despite improving financial performance. The upcoming report is expected to provide key insights into the company's operations in the Canadian cannabis and liquor retail markets.

SNDL Financials: Revenue Breakdown, Margins & Competitor Comparison

This article provides an analysis of SNDL Inc.'s financial performance, focusing on its revenue breakdown, profitability margins, and a comparison with competitors. SNDL primarily generates revenue from liquor retail, and its gross margin is highlighted against other companies in the Pharmaceuticals industry. The analysis aims to help investors understand SNDL's market position and efficiency.

$SNDLLow

SNDL Appoints Interim Cannabis President as Tyler Robson Departs

SNDL Inc. has announced the departure of its President of Cannabis, Tyler Robson, who is leaving to pursue other opportunities. Chief Strategy Officer Ryan Hellard will assume the role of Interim President of Cannabis to ensure continuity in the company's core cannabis operations and strategy. The company is balancing its roles as a major cannabis producer and retailer in Canada, and investors will be watching for potential shifts in corporate direction.

$SNDLMed

SNDL Inc. (NASDAQ:SNDL) Sees Large Increase in Short Interest

SNDL Inc. (NASDAQ:SNDL) experienced a significant 25.6% increase in short interest in March, reaching 2,152,216 shares. Despite a consensus "Hold" rating and a $5.00 price target from analysts, the company's financial performance shows a mix of beating EPS estimates but missing revenue expectations, and it has a negative forecast for the current fiscal year's EPS. Institutional investors have been both buying and selling shares, while the stock currently trades around $1.29 with a market cap of $330.76 million.

Related tickers